Literature DB >> 6194281

Postnatal changes in erythropoietin levels in untransfused premature infants.

M S Brown, R H Phibbs, J F Garcia, P R Dallman.   

Abstract

The purpose of this study was to determine whether an inappropriately low erythropoietin response in premature infants might be a basis for the anemia of prematurity. Erythropoietin was measured by radioimmunoassay in conjunction with hemoglobin and reticulocyte count in untransfused premature infants between birth and 60 days of age. The 27 infants had a mean gestational age of 31 weeks and a mean birth weight of 1378 gm. Between 2 and 30 days, mean erythropoietin concentration was 9.7 mU/ml, significantly and substantially lower than 15.2 mU/ml in 15 concurrently studied healthy adults (P less than 0.01). Subsequently, from 30 to 60 days, values rose gradually to a mean of 17.2 mU/ml, which did not differ significantly from the mean value in adults. Hemoglobin values fell from a mean of 12.9 gm/dl during the first month to 9.0 gm/dl between 30 and 60 days. Thus, during the second postnatal month, preterm infants had essentially the same erythropoietin values as in adults despite a mean hemoglobin concentration that averaged less than two thirds the adult value. This failure to mount a greater erythropoietin response may help to explain why hemoglobin declines to such low values at 2 months of age.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194281     DOI: 10.1016/s0022-3476(83)80600-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  19 in total

1.  Serum erythropoietin concentrations in symptomatic infants during the anaemia of prematurity.

Authors:  J Meyer; A Sive; P Jacobs
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

Review 2.  Early erythropoiesis-stimulating agents in preterm or low birth weight infants.

Authors:  Arne Ohlsson; Sanjay M Aher
Journal:  Cochrane Database Syst Rev       Date:  2017-11-16

3.  Hyperviscosity in the newborn: the scope of the problem.

Authors:  M H LeBlanc; K Pate
Journal:  Bull N Y Acad Med       Date:  1986-05

4.  Role of erythropoietin in the newborn.

Authors:  A J Emmerson
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

5.  Blood transfusion in the preterm infant.

Authors:  P Dear
Journal:  Arch Dis Child       Date:  1984-04       Impact factor: 3.791

6.  Haemoglobin concentration depends on protein intake in small preterm infants fed human milk.

Authors:  K A Rönnholm; M A Siimes
Journal:  Arch Dis Child       Date:  1985-02       Impact factor: 3.791

7.  Comparison of the effects of theophylline and caffeine on serum erythropoietin concentration in premature infants.

Authors:  S Fang; R A Sherwood; H R Gamsu; J T Marsden; T J Peters; A Greenough
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

8.  Serum immunoreactive erythropoietin of children in health and disease.

Authors:  K U Eckardt; W Hartmann; U Vetter; F Pohlandt; R Burghardt; A Kurtz
Journal:  Eur J Pediatr       Date:  1990-04       Impact factor: 3.183

9.  Circulating hematopoietic and endothelial progenitor cells in newborn infants: effects of gestational age, postnatal age and clinical stress in the first 3 weeks of life.

Authors:  Kim Chi T Bui; Mark Weems; Manoj Biniwale; Aswathi A George; Ewa Zielinska; Colleen G Azen; Manuel Durand; Hisham Abdel-Azim
Journal:  Early Hum Dev       Date:  2013-01-09       Impact factor: 2.079

10.  Double blind trial of recombinant human erythropoietin in preterm infants.

Authors:  A J Emmerson; H J Coles; C M Stern; T C Pearson
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.